<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03948048</url>
  </required_header>
  <id_info>
    <org_study_id>fdpicu-03</org_study_id>
    <nct_id>NCT03948048</nct_id>
  </id_info>
  <brief_title>Study on the Efficacy and Timing of ECMO Therapy in Children With Refractory Septic Shock</brief_title>
  <official_title>Study on the Efficacy and Timing of ECMO Therapy in Children With Refractory Septic</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Children's Hospital of Fudan University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Shanghai Children's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Beijing Children's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Zhengzhou Children's Hospital, China</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Chinese PLA General Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Children's Hospital of Zhejiang University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Children's Hospital of Chongqing Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Shengjing Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Children's Hospital of Fudan University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Severe sepsis and septic shock remain the leading causes of child mortality worldwide. Sepsis
      is a complex process that ultimately leads to circulation disorders, organ perfusion
      abnormalities, capillary leakage, tissue hypoxia, and organ failure. The difficulty of
      clinical treatment is microcirculation and mitochondrial dysfunction in septic shock. Once
      shock enters the stage of microcirculation failure, conventional treatment is ineffective.
      ECMO can effectively support the circulatory system and provide good oxygen delivery, but
      there are many controversies in clinical treatment. 1) whether ECMO can effectively improve
      the clinical prognosis of children with septic shock; 2) appropriate timing for ECMO
      intervention; 3) which key clinical factors affect the effect of ECMO treatment. This study
      intends to adopt a multi-center, prospective, non-randomized controlled trial design, and the
      main research hypothesis is whether ECMO treatment can improve the success of discharge
      survival of children with septic shock.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this study, a variety of statistical analysis methods will be used to screen the clinical
      indicators and truncation values suitable for starting ECMO, and to construct a comprehensive
      prediction model, so as to determine the basis for the optimal timing of ECMO treatment in
      the future. The efficacy of ScVO2, lactic acid, and VIS on the ECMO treatment timing will
      also be evaluated. This study aims to evaluate and improve the clinical application of ECMO
      in the treatment of sepsis in children
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 1, 2019</start_date>
  <completion_date type="Anticipated">August 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">August 31, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Survival rate</measure>
    <time_frame>28 days</time_frame>
    <description>The survival rate of children in 28 days after hospital discharge</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>ECMO weaning rate</measure>
    <time_frame>48 hours</time_frame>
    <description>The success of ECMO weaning is defined as the survival of patients after ECMO weaning for 48 hours</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Septic Shock</condition>
  <condition>Extracorporeal Membrane Oxygenation Complication</condition>
  <arm_group>
    <arm_group_label>septic shock</arm_group_label>
    <description>The critically ill children with septic shock (ss group)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>refractory septic shock with ECMO</arm_group_label>
    <description>The critically ill children with refractory septic shock with ECMO treatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>refractory septic shock without ECMO</arm_group_label>
    <description>The critically ill children prediction model th refractory septic shock without ECMO treatment</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ECMO</intervention_name>
    <description>ECMO is used to intervene septic shock and refractory septic shock</description>
    <arm_group_label>refractory septic shock with ECMO</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Children with septic shock and refractory septic shock admitted to the PICU of all the
        study centers
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Children with septic shock and refractory septic shock admitted to the PICU of all the
             study centers

        Exclusion Criteria:

          -  1. Fatal chromosomal abnormalities (e.g., trisomy 13 or 18) 2. Uncontrolled bleeding
             3. Irreversible brain damage 4. After allogeneic bone marrow transplantation 5. Weight
             less than 2.5kg or severe malnutrition
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Guoping Lu, Doctor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Children's Hospital of Fudan University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Guoping Lu, Doctor</last_name>
    <phone>+8613788904150</phone>
    <email>13788904150@163.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ye Cheng, Master</last_name>
    <phone>+8613816566641</phone>
    <email>Cheng18017591034@163.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Children'S Hosptial of Fuan University</name>
      <address>
        <city>Shanghai</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>May 2019</verification_date>
  <study_first_submitted>May 10, 2019</study_first_submitted>
  <study_first_submitted_qc>May 10, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 13, 2019</study_first_posted>
  <last_update_submitted>May 10, 2019</last_update_submitted>
  <last_update_submitted_qc>May 10, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">May 13, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>septic shock</keyword>
  <keyword>children</keyword>
  <keyword>ECMO</keyword>
  <keyword>timing</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Shock, Septic</mesh_term>
    <mesh_term>Shock</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

